Statements (11)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Urovant_Sciences,_Inc.
|
| gptkbp:CEO |
James_M._McEleny
|
| gptkbp:develops |
therapies for overactive bladder
|
| gptkbp:focusesOn |
urology
|
| gptkbp:founded |
2018
|
| gptkbp:headquarters |
gptkb:San_Diego,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Urovant Sciences
|
| gptkbp:partnerships |
gptkb:Sumitomo_Dainippon_Pharma
|
| gptkbp:sells |
UROV
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|